Dr. Ferrer BioPharma: Clinical Trials

2 completed, 1 unknown. 2 Phase 2, 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2
Phase 3	2	Completed 2

Follow Dr. Ferrer BioPharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III Chlorpheniramine Maleate 0.4% Nasal Spray, Placebo - COVID-19, Symptoms and Signs	Phase 2 / Phase 3	Completed	Dr. Ferrer BioPharma	157	2022-07-27	2023-06-02
Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I Chlorpheniramine Maleate 1% Nasal Spray, Placebo - COVID-19, Symptoms and Signs	Phase 2 / Phase 3	Completed	Dr. Ferrer BioPharma	101	2021-12-07	2023-03-23
Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis ClorNovir® (Chlorpheniramine) 0.4% Nasal Spray - COVID-19, COVID-19 Pandemic		Unknown	Dr. Ferrer BioPharma	1000	2021-08-26	2022-08-30

Conditions studied

COVID-19 (3)  ·  Coronavirus Infections (2)  ·  Signs and Symptoms (2)

Interventions

Chlorpheniramine (3)  ·  Nasal Sprays (3)

Countries

Honduras (2)  ·  Dominican Republic (1)